Results 11 to 20 of about 14,714 (182)

Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy. [PDF]

MedComm (2020)
Hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS) insertion constitutes a frequent and severe complication, however, biomarkers are currently scarce. The results of this study indicate that neurofilament light chains (NfL) in serum, but not glial fibrillary acidic protein (GFAP), is a useful biomarker identifying ...
Labenz C, Schleicher EM, Meineck M, Kabelitz MA, Ehrenbauer AF, Tiede A, Mauz JB, Danneberg S, Pitton MB, Steffen F, Weinmann-Menke J, Galle PR, Bittner S, Lüssi F, Marquardt JU, Maasoumy B, Gairing SJ.   +16 more
europepmc   +2 more sources

Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS

Hepatology, EarlyView., 2022
The river diagram demonstrates that after transjugular intrahepatic portosystemic shunt insertion (TIPS) the majority of patients without ascites and 50% of the patients with ascites detectable at ultrasound, show the best response in the long term follow‐up.
Alexander Queck, Louise Schwierz, Wenyi Gu, Philip G. Ferstl, Christian Jansen, Frank E. Uschner, Michael Praktiknjo, Johannes Chang, Maximilian J. Brol, Filippo Schepis, Manuela Merli, Christian P. Strassburg, Jennifer Lehmann, Carsten Meyer, Jonel Trebicka   +14 more
wiley   +1 more source

Health disparities in chronic liver disease

Hepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew   +3 more
wiley   +1 more source

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

Hepatology, EarlyView., 2022
Diagram of the activation of the profibrotic and procontractile Janus kinase 2 (JAK2)/Ras homolog family member A/Rho‐kinase pathway and the inhibition of phosphorylated JAK2 by pacritinib to inhibit hepatic stellate cell activity. Abstract Background and Aims Janus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with ...
Sandra Torres, Cristina Ortiz, Nadine Bachtler, Wenyi Gu, Leon D. Grünewald, Nico Kraus, Robert Schierwagen, Christoph Hieber, Caroline Meier, Olaf Tyc, Maximilian Joseph Brol, Frank Erhard Uschner, Bart Nijmeijer, Christoph Welsch, Marie‐Luise Berres, Carmen Garcia‐Ruiz, Jose Carlos Fernandez‐Checa, Christian Trautwein, Thomas J. Vogl, Stefan Zeuzem, Jonel Trebicka, Sabine Klein   +21 more
wiley   +1 more source

Preliminary clinical observation of double C-arm digital subtraction angiography guidance during transjugular intrahepatic portosystemic shunt placement

BMC Gastroenterology, 2023
Background This study aimed to investigate the safety, preliminary clinical experience, and technical advantages of double C-arm digital subtraction angiography -assisted portal vein puncture for transjugular intrahepatic portosystemic shunt.
Jianqiao Chen, Xiao Bai, Chunyan Wang, Jihua Li, Weiguo Xu   +4 more
doaj   +1 more source

Portovenography Findings Following Partial Polypropylene Versus Thin Film Band Attenuation of a Single Congenital Extrahepatic Portosystemic Shunt: A Prospective Randomized Study in Dogs

Veterinary Sciences, 2023
The objective was to conduct a prospective, randomized study to compare mesenteric portovenogram findings following partial polypropylene suture versus thin film band extrahepatic portosystemic shunt attenuation in dogs.
Victoria Lipscomb, Mickey Tivers, Anne Kummeling, Freek van Sluijs   +3 more
doaj   +1 more source

Percutaneous transvenous coil embolization of an extrahepatic portosystemic shunt in a cat

Journal of Feline Medicine and Surgery Open Reports, 2022
Case summary A 10-month-old male domestic shorthair cat presented for surgical treatment of a congenital portosystemic shunt. The cat had a history of lethargy and ptyalism. Pre- and postprandial bile acids were markedly elevated. CT was performed, which
J Brad Case, Francesca P Solari, Federico Vilaplana Grosso   +2 more
doaj   +1 more source

Transportal Technetium-99m Labeled Macroaggregated Albumin Scintigraphy to Quantify Occult Intrahepatic Microvascular Portosystemic Shunting

Radiology Case Reports, 2021
Nodular regenerative hyperplasia (NRH) of the liver may lead to noncirrhotic portal hypertension with subsequent development of portosystemic shunts. While extrahepatic and macrovascular shunts are readily visualized with imaging or endoscopy, there is ...
Cynthia De la Garza-Ramos, MD, Mohamed S. Muneer, MD, Jason T. Lewis, MD, Denise M. Harnois, DO, C. Burcin Taner, MD, Gregory T. Frey, MD, Barry Rosser, MD, Beau B. Toskich, MD   +7 more
doaj   +1 more source

Transhepatic embolization of a congenital intrahepatic portosystemic shunt for the treatment of hepatic encephalopathy in a noncirrhotic patient using Amplatzer vascular plug device

Radiology Case Reports, 2017
A 73-year-old male with no history of liver disease was hospitalized for weakness, confusion, ataxia, and new onset hepatic encephalopathy with hyperammonemia.
Rachel Ann Brader, BS, Kyung Rae Kim, MD
doaj   +1 more source

Asymptomatic congenital intrahepatic portosystemic shunt

Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2022
Spontaneous asymptomatic intrahepatic portosystemic shunt is a rare anomaly of the hepatic vasculature. The main clinical manifestations may be encephalopathy, bleeding or hyperinsulinism, due to the constant shedding of blood.
E. A. Sidorov, P. M. Zelter, D. V. Solovov, А. А. Manukyan   +3 more
doaj   +1 more source